These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9880383)

  • 1. Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients.
    Wahlgren NG; Ranasinha KW; Rosolacci T; Franke CL; van Erven PM; Ashwood T; Claesson L
    Stroke; 1999 Jan; 30(1):21-8. PubMed ID: 9880383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients.
    Wahlgren NG; Díez-Tejedor E; Teitelbaum J; Arboix A; Leys D; Ashwood T; Grossman E
    Stroke; 2000 Jan; 31(1):82-5. PubMed ID: 10625720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results.
    Lyden P; Jacoby M; Schim J; Albers G; Mazzeo P; Ashwood T; Nordlund A; Odergren T
    Neurology; 2001 Oct; 57(7):1199-205. PubMed ID: 11591835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results.
    Lyden P; Shuaib A; Ng K; Levin K; Atkinson RP; Rajput A; Wechsler L; Ashwood T; Claesson L; Odergren T; Salazar-Grueso E;
    Stroke; 2002 Jan; 33(1):122-8. PubMed ID: 11779900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clomethiazole acute stroke study (CLASS): Safety results in 1,356 patients with acute hemispheric stroke.
    Wahlgren NG; Matias-Guiu J; Lainez JM; Veloso F; Ranasinha K; Grossman E; Ashwood T;
    J Stroke Cerebrovasc Dis; 2000; 9(4):158-65. PubMed ID: 24192021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS).
    Wahlgren NG; Bornhov S; Sharma A; Cederin B; Rosolacci T; Ashwood T; Claesson L;
    J Stroke Cerebrovasc Dis; 1999; 8(4):231-9. PubMed ID: 17895170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
    De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
    Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
    Dyker AG; Lees KR
    Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
    Grotta J
    Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
    Diener HC
    Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.
    Zingmark PH; Ekblom M; Odergren T; Ashwood T; Lyden P; Karlsson MO; Jonsson EN
    Br J Clin Pharmacol; 2003 Aug; 56(2):173-83. PubMed ID: 12895190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
    Diener HC; Hacke W; Hennerici M; Rådberg J; Hantson L; De Keyser J
    Stroke; 1996 Jan; 27(1):76-81. PubMed ID: 8553408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of the neuroprotectant clomethiazole in coronary artery bypass graft surgery: a randomized controlled trial.
    Kong RS; Butterworth J; Aveling W; Stump DA; Harrison MJ; Hammon J; Stygall J; Rorie KD; Newman SP
    Anesthesiology; 2002 Sep; 97(3):585-91. PubMed ID: 12218524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.
    Diener HC; Cortens M; Ford G; Grotta J; Hacke W; Kaste M; Koudstaal PJ; Wessel T
    Stroke; 2000 Nov; 31(11):2543-51. PubMed ID: 11062273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
    J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
    Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
    Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.